nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—CYP3A7—Vincristine—sarcoma	0.077	0.116	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.077	0.116	CbGbCtD
Nefazodone—CYP3A4—Thiotepa—sarcoma	0.0761	0.115	CbGbCtD
Nefazodone—ABCB1—Dactinomycin—sarcoma	0.061	0.0919	CbGbCtD
Nefazodone—CYP3A5—Vincristine—sarcoma	0.0577	0.087	CbGbCtD
Nefazodone—ABCB1—Mitoxantrone—sarcoma	0.0546	0.0822	CbGbCtD
Nefazodone—CYP3A5—Etoposide—sarcoma	0.0529	0.0797	CbGbCtD
Nefazodone—ABCB1—Vincristine—sarcoma	0.0376	0.0566	CbGbCtD
Nefazodone—ABCB1—Etoposide—sarcoma	0.0344	0.0519	CbGbCtD
Nefazodone—CYP3A4—Mitoxantrone—sarcoma	0.0327	0.0493	CbGbCtD
Nefazodone—ABCB1—Doxorubicin—sarcoma	0.0235	0.0354	CbGbCtD
Nefazodone—CYP3A4—Vincristine—sarcoma	0.0225	0.0339	CbGbCtD
Nefazodone—CYP2D6—Doxorubicin—sarcoma	0.0221	0.0333	CbGbCtD
Nefazodone—CYP3A4—Etoposide—sarcoma	0.0206	0.0311	CbGbCtD
Nefazodone—CYP3A4—Doxorubicin—sarcoma	0.0141	0.0212	CbGbCtD
Nefazodone—Feeling abnormal—Mitoxantrone—sarcoma	0.000405	0.00121	CcSEcCtD
Nefazodone—Asthma—Epirubicin—sarcoma	0.000403	0.0012	CcSEcCtD
Nefazodone—Influenza—Epirubicin—sarcoma	0.000403	0.0012	CcSEcCtD
Nefazodone—Dysphagia—Epirubicin—sarcoma	0.000403	0.0012	CcSEcCtD
Nefazodone—Pruritus—Thiotepa—sarcoma	0.000403	0.0012	CcSEcCtD
Nefazodone—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000402	0.0012	CcSEcCtD
Nefazodone—Dehydration—Doxorubicin—sarcoma	0.000401	0.00119	CcSEcCtD
Nefazodone—Thrombocytopenia—Etoposide—sarcoma	0.0004	0.00119	CcSEcCtD
Nefazodone—Tachycardia—Etoposide—sarcoma	0.000399	0.00119	CcSEcCtD
Nefazodone—Abdominal pain—Vincristine—sarcoma	0.000399	0.00119	CcSEcCtD
Nefazodone—Body temperature increased—Vincristine—sarcoma	0.000399	0.00119	CcSEcCtD
Nefazodone—Liver function test abnormal—Doxorubicin—sarcoma	0.000398	0.00119	CcSEcCtD
Nefazodone—Dry skin—Doxorubicin—sarcoma	0.000395	0.00118	CcSEcCtD
Nefazodone—Hyperhidrosis—Etoposide—sarcoma	0.000395	0.00118	CcSEcCtD
Nefazodone—Orthostatic hypotension—Doxorubicin—sarcoma	0.000394	0.00117	CcSEcCtD
Nefazodone—Angina pectoris—Epirubicin—sarcoma	0.000393	0.00117	CcSEcCtD
Nefazodone—Urticaria—Mitoxantrone—sarcoma	0.00039	0.00116	CcSEcCtD
Nefazodone—Anorexia—Etoposide—sarcoma	0.00039	0.00116	CcSEcCtD
Nefazodone—Diarrhoea—Thiotepa—sarcoma	0.000389	0.00116	CcSEcCtD
Nefazodone—Abdominal pain—Mitoxantrone—sarcoma	0.000389	0.00116	CcSEcCtD
Nefazodone—Body temperature increased—Mitoxantrone—sarcoma	0.000389	0.00116	CcSEcCtD
Nefazodone—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000389	0.00116	CcSEcCtD
Nefazodone—Bronchitis—Epirubicin—sarcoma	0.000388	0.00115	CcSEcCtD
Nefazodone—Diarrhoea—Dactinomycin—sarcoma	0.000387	0.00115	CcSEcCtD
Nefazodone—Hypotension—Etoposide—sarcoma	0.000382	0.00114	CcSEcCtD
Nefazodone—Gastritis—Doxorubicin—sarcoma	0.000382	0.00114	CcSEcCtD
Nefazodone—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000381	0.00113	CcSEcCtD
Nefazodone—Dysuria—Epirubicin—sarcoma	0.000377	0.00112	CcSEcCtD
Nefazodone—Dizziness—Thiotepa—sarcoma	0.000376	0.00112	CcSEcCtD
Nefazodone—Abdominal distension—Doxorubicin—sarcoma	0.000375	0.00112	CcSEcCtD
Nefazodone—Dysphagia—Doxorubicin—sarcoma	0.000373	0.00111	CcSEcCtD
Nefazodone—Influenza—Doxorubicin—sarcoma	0.000373	0.00111	CcSEcCtD
Nefazodone—Asthma—Doxorubicin—sarcoma	0.000373	0.00111	CcSEcCtD
Nefazodone—Pollakiuria—Epirubicin—sarcoma	0.000372	0.00111	CcSEcCtD
Nefazodone—Hypersensitivity—Vincristine—sarcoma	0.000372	0.00111	CcSEcCtD
Nefazodone—Photosensitivity reaction—Epirubicin—sarcoma	0.000368	0.00109	CcSEcCtD
Nefazodone—Paraesthesia—Etoposide—sarcoma	0.000367	0.00109	CcSEcCtD
Nefazodone—Weight increased—Epirubicin—sarcoma	0.000367	0.00109	CcSEcCtD
Nefazodone—Weight decreased—Epirubicin—sarcoma	0.000365	0.00108	CcSEcCtD
Nefazodone—Dyspnoea—Etoposide—sarcoma	0.000365	0.00108	CcSEcCtD
Nefazodone—Somnolence—Etoposide—sarcoma	0.000363	0.00108	CcSEcCtD
Nefazodone—Angina pectoris—Doxorubicin—sarcoma	0.000363	0.00108	CcSEcCtD
Nefazodone—Hypersensitivity—Mitoxantrone—sarcoma	0.000362	0.00108	CcSEcCtD
Nefazodone—Asthenia—Vincristine—sarcoma	0.000362	0.00108	CcSEcCtD
Nefazodone—Vomiting—Thiotepa—sarcoma	0.000362	0.00108	CcSEcCtD
Nefazodone—Pneumonia—Epirubicin—sarcoma	0.000361	0.00108	CcSEcCtD
Nefazodone—Vomiting—Dactinomycin—sarcoma	0.000359	0.00107	CcSEcCtD
Nefazodone—Rash—Thiotepa—sarcoma	0.000359	0.00107	CcSEcCtD
Nefazodone—Bronchitis—Doxorubicin—sarcoma	0.000359	0.00107	CcSEcCtD
Nefazodone—Dermatitis—Thiotepa—sarcoma	0.000359	0.00107	CcSEcCtD
Nefazodone—Headache—Thiotepa—sarcoma	0.000357	0.00106	CcSEcCtD
Nefazodone—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000356	0.00106	CcSEcCtD
Nefazodone—Rash—Dactinomycin—sarcoma	0.000356	0.00106	CcSEcCtD
Nefazodone—Decreased appetite—Etoposide—sarcoma	0.000355	0.00106	CcSEcCtD
Nefazodone—Asthenia—Mitoxantrone—sarcoma	0.000353	0.00105	CcSEcCtD
Nefazodone—Stomatitis—Epirubicin—sarcoma	0.00035	0.00104	CcSEcCtD
Nefazodone—Pain—Etoposide—sarcoma	0.00035	0.00104	CcSEcCtD
Nefazodone—Constipation—Etoposide—sarcoma	0.00035	0.00104	CcSEcCtD
Nefazodone—Conjunctivitis—Epirubicin—sarcoma	0.000349	0.00104	CcSEcCtD
Nefazodone—Urinary tract infection—Epirubicin—sarcoma	0.000349	0.00104	CcSEcCtD
Nefazodone—Dysuria—Doxorubicin—sarcoma	0.000349	0.00104	CcSEcCtD
Nefazodone—Diarrhoea—Vincristine—sarcoma	0.000345	0.00103	CcSEcCtD
Nefazodone—Sweating—Epirubicin—sarcoma	0.000344	0.00102	CcSEcCtD
Nefazodone—Pollakiuria—Doxorubicin—sarcoma	0.000344	0.00102	CcSEcCtD
Nefazodone—Haematuria—Epirubicin—sarcoma	0.000343	0.00102	CcSEcCtD
Nefazodone—Photosensitivity reaction—Doxorubicin—sarcoma	0.00034	0.00101	CcSEcCtD
Nefazodone—Weight increased—Doxorubicin—sarcoma	0.000339	0.00101	CcSEcCtD
Nefazodone—Epistaxis—Epirubicin—sarcoma	0.000339	0.00101	CcSEcCtD
Nefazodone—Nausea—Thiotepa—sarcoma	0.000338	0.00101	CcSEcCtD
Nefazodone—Weight decreased—Doxorubicin—sarcoma	0.000337	0.001	CcSEcCtD
Nefazodone—Sinusitis—Epirubicin—sarcoma	0.000337	0.001	CcSEcCtD
Nefazodone—Feeling abnormal—Etoposide—sarcoma	0.000337	0.001	CcSEcCtD
Nefazodone—Diarrhoea—Mitoxantrone—sarcoma	0.000336	0.001	CcSEcCtD
Nefazodone—Nausea—Dactinomycin—sarcoma	0.000336	0.000998	CcSEcCtD
Nefazodone—Pneumonia—Doxorubicin—sarcoma	0.000334	0.000995	CcSEcCtD
Nefazodone—Gastrointestinal pain—Etoposide—sarcoma	0.000334	0.000995	CcSEcCtD
Nefazodone—Dizziness—Vincristine—sarcoma	0.000334	0.000993	CcSEcCtD
Nefazodone—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00033	0.000981	CcSEcCtD
Nefazodone—Bradycardia—Epirubicin—sarcoma	0.000328	0.000977	CcSEcCtD
Nefazodone—Urticaria—Etoposide—sarcoma	0.000325	0.000966	CcSEcCtD
Nefazodone—Haemoglobin—Epirubicin—sarcoma	0.000324	0.000965	CcSEcCtD
Nefazodone—Stomatitis—Doxorubicin—sarcoma	0.000324	0.000964	CcSEcCtD
Nefazodone—Rhinitis—Epirubicin—sarcoma	0.000323	0.000962	CcSEcCtD
Nefazodone—Body temperature increased—Etoposide—sarcoma	0.000323	0.000962	CcSEcCtD
Nefazodone—Abdominal pain—Etoposide—sarcoma	0.000323	0.000962	CcSEcCtD
Nefazodone—Conjunctivitis—Doxorubicin—sarcoma	0.000323	0.000962	CcSEcCtD
Nefazodone—Urinary tract infection—Doxorubicin—sarcoma	0.000323	0.000962	CcSEcCtD
Nefazodone—Hepatitis—Epirubicin—sarcoma	0.000323	0.00096	CcSEcCtD
Nefazodone—Haemorrhage—Epirubicin—sarcoma	0.000323	0.00096	CcSEcCtD
Nefazodone—Hypoaesthesia—Epirubicin—sarcoma	0.000321	0.000955	CcSEcCtD
Nefazodone—Vomiting—Vincristine—sarcoma	0.000321	0.000955	CcSEcCtD
Nefazodone—Pharyngitis—Epirubicin—sarcoma	0.00032	0.000953	CcSEcCtD
Nefazodone—Sweating—Doxorubicin—sarcoma	0.000319	0.000948	CcSEcCtD
Nefazodone—Rash—Vincristine—sarcoma	0.000318	0.000947	CcSEcCtD
Nefazodone—Dermatitis—Vincristine—sarcoma	0.000318	0.000946	CcSEcCtD
Nefazodone—Oedema peripheral—Epirubicin—sarcoma	0.000318	0.000945	CcSEcCtD
Nefazodone—Haematuria—Doxorubicin—sarcoma	0.000317	0.000943	CcSEcCtD
Nefazodone—Headache—Vincristine—sarcoma	0.000316	0.000941	CcSEcCtD
Nefazodone—Epistaxis—Doxorubicin—sarcoma	0.000314	0.000933	CcSEcCtD
Nefazodone—Vomiting—Mitoxantrone—sarcoma	0.000313	0.00093	CcSEcCtD
Nefazodone—Sinusitis—Doxorubicin—sarcoma	0.000312	0.000928	CcSEcCtD
Nefazodone—Visual impairment—Epirubicin—sarcoma	0.000311	0.000925	CcSEcCtD
Nefazodone—Rash—Mitoxantrone—sarcoma	0.00031	0.000922	CcSEcCtD
Nefazodone—Dermatitis—Mitoxantrone—sarcoma	0.00031	0.000921	CcSEcCtD
Nefazodone—Headache—Mitoxantrone—sarcoma	0.000308	0.000916	CcSEcCtD
Nefazodone—Erythema multiforme—Epirubicin—sarcoma	0.000305	0.000907	CcSEcCtD
Nefazodone—Bradycardia—Doxorubicin—sarcoma	0.000304	0.000904	CcSEcCtD
Nefazodone—Hypersensitivity—Etoposide—sarcoma	0.000301	0.000896	CcSEcCtD
Nefazodone—Tinnitus—Epirubicin—sarcoma	0.000301	0.000895	CcSEcCtD
Nefazodone—Haemoglobin—Doxorubicin—sarcoma	0.0003	0.000893	CcSEcCtD
Nefazodone—Nausea—Vincristine—sarcoma	0.0003	0.000892	CcSEcCtD
Nefazodone—Flushing—Epirubicin—sarcoma	0.000299	0.000891	CcSEcCtD
Nefazodone—Rhinitis—Doxorubicin—sarcoma	0.000299	0.00089	CcSEcCtD
Nefazodone—Hepatitis—Doxorubicin—sarcoma	0.000298	0.000888	CcSEcCtD
Nefazodone—Haemorrhage—Doxorubicin—sarcoma	0.000298	0.000888	CcSEcCtD
Nefazodone—Hypoaesthesia—Doxorubicin—sarcoma	0.000297	0.000884	CcSEcCtD
Nefazodone—Pharyngitis—Doxorubicin—sarcoma	0.000296	0.000881	CcSEcCtD
Nefazodone—Oedema peripheral—Doxorubicin—sarcoma	0.000294	0.000875	CcSEcCtD
Nefazodone—Asthenia—Etoposide—sarcoma	0.000293	0.000873	CcSEcCtD
Nefazodone—Nausea—Mitoxantrone—sarcoma	0.000292	0.000869	CcSEcCtD
Nefazodone—Chills—Epirubicin—sarcoma	0.000289	0.000861	CcSEcCtD
Nefazodone—Pruritus—Etoposide—sarcoma	0.000289	0.000861	CcSEcCtD
Nefazodone—Visual impairment—Doxorubicin—sarcoma	0.000288	0.000856	CcSEcCtD
Nefazodone—Alopecia—Epirubicin—sarcoma	0.000285	0.000848	CcSEcCtD
Nefazodone—Erythema multiforme—Doxorubicin—sarcoma	0.000282	0.00084	CcSEcCtD
Nefazodone—Diarrhoea—Etoposide—sarcoma	0.00028	0.000832	CcSEcCtD
Nefazodone—Tinnitus—Doxorubicin—sarcoma	0.000278	0.000828	CcSEcCtD
Nefazodone—Flushing—Doxorubicin—sarcoma	0.000277	0.000824	CcSEcCtD
Nefazodone—Flatulence—Epirubicin—sarcoma	0.000277	0.000823	CcSEcCtD
Nefazodone—Dysgeusia—Epirubicin—sarcoma	0.000275	0.000818	CcSEcCtD
Nefazodone—Back pain—Epirubicin—sarcoma	0.000272	0.000808	CcSEcCtD
Nefazodone—Dizziness—Etoposide—sarcoma	0.00027	0.000804	CcSEcCtD
Nefazodone—Muscle spasms—Epirubicin—sarcoma	0.00027	0.000803	CcSEcCtD
Nefazodone—Chills—Doxorubicin—sarcoma	0.000268	0.000797	CcSEcCtD
Nefazodone—Vision blurred—Epirubicin—sarcoma	0.000265	0.000787	CcSEcCtD
Nefazodone—Alopecia—Doxorubicin—sarcoma	0.000264	0.000785	CcSEcCtD
Nefazodone—Ill-defined disorder—Epirubicin—sarcoma	0.000261	0.000775	CcSEcCtD
Nefazodone—Vomiting—Etoposide—sarcoma	0.00026	0.000773	CcSEcCtD
Nefazodone—Anaemia—Epirubicin—sarcoma	0.00026	0.000772	CcSEcCtD
Nefazodone—Agitation—Epirubicin—sarcoma	0.000258	0.000768	CcSEcCtD
Nefazodone—Rash—Etoposide—sarcoma	0.000258	0.000767	CcSEcCtD
Nefazodone—Dermatitis—Etoposide—sarcoma	0.000258	0.000766	CcSEcCtD
Nefazodone—Headache—Etoposide—sarcoma	0.000256	0.000762	CcSEcCtD
Nefazodone—Flatulence—Doxorubicin—sarcoma	0.000256	0.000762	CcSEcCtD
Nefazodone—Dysgeusia—Doxorubicin—sarcoma	0.000254	0.000757	CcSEcCtD
Nefazodone—Malaise—Epirubicin—sarcoma	0.000253	0.000753	CcSEcCtD
Nefazodone—Vertigo—Epirubicin—sarcoma	0.000252	0.000751	CcSEcCtD
Nefazodone—Syncope—Epirubicin—sarcoma	0.000252	0.000749	CcSEcCtD
Nefazodone—Leukopenia—Epirubicin—sarcoma	0.000251	0.000748	CcSEcCtD
Nefazodone—Back pain—Doxorubicin—sarcoma	0.000251	0.000748	CcSEcCtD
Nefazodone—Muscle spasms—Doxorubicin—sarcoma	0.00025	0.000743	CcSEcCtD
Nefazodone—Palpitations—Epirubicin—sarcoma	0.000248	0.000738	CcSEcCtD
Nefazodone—Loss of consciousness—Epirubicin—sarcoma	0.000247	0.000734	CcSEcCtD
Nefazodone—Cough—Epirubicin—sarcoma	0.000245	0.000729	CcSEcCtD
Nefazodone—Vision blurred—Doxorubicin—sarcoma	0.000245	0.000729	CcSEcCtD
Nefazodone—Convulsion—Epirubicin—sarcoma	0.000243	0.000724	CcSEcCtD
Nefazodone—Nausea—Etoposide—sarcoma	0.000243	0.000723	CcSEcCtD
Nefazodone—Hypertension—Epirubicin—sarcoma	0.000242	0.000721	CcSEcCtD
Nefazodone—Ill-defined disorder—Doxorubicin—sarcoma	0.000241	0.000717	CcSEcCtD
Nefazodone—Anaemia—Doxorubicin—sarcoma	0.00024	0.000715	CcSEcCtD
Nefazodone—Arthralgia—Epirubicin—sarcoma	0.000239	0.000711	CcSEcCtD
Nefazodone—Chest pain—Epirubicin—sarcoma	0.000239	0.000711	CcSEcCtD
Nefazodone—Myalgia—Epirubicin—sarcoma	0.000239	0.000711	CcSEcCtD
Nefazodone—Agitation—Doxorubicin—sarcoma	0.000239	0.00071	CcSEcCtD
Nefazodone—Anxiety—Epirubicin—sarcoma	0.000238	0.000709	CcSEcCtD
Nefazodone—Discomfort—Epirubicin—sarcoma	0.000236	0.000703	CcSEcCtD
Nefazodone—Malaise—Doxorubicin—sarcoma	0.000234	0.000697	CcSEcCtD
Nefazodone—Dry mouth—Epirubicin—sarcoma	0.000234	0.000696	CcSEcCtD
Nefazodone—Vertigo—Doxorubicin—sarcoma	0.000233	0.000695	CcSEcCtD
Nefazodone—Syncope—Doxorubicin—sarcoma	0.000233	0.000693	CcSEcCtD
Nefazodone—Leukopenia—Doxorubicin—sarcoma	0.000233	0.000692	CcSEcCtD
Nefazodone—Confusional state—Epirubicin—sarcoma	0.000231	0.000688	CcSEcCtD
Nefazodone—Palpitations—Doxorubicin—sarcoma	0.00023	0.000683	CcSEcCtD
Nefazodone—Anaphylactic shock—Epirubicin—sarcoma	0.000229	0.000682	CcSEcCtD
Nefazodone—Oedema—Epirubicin—sarcoma	0.000229	0.000682	CcSEcCtD
Nefazodone—Loss of consciousness—Doxorubicin—sarcoma	0.000228	0.000679	CcSEcCtD
Nefazodone—Infection—Epirubicin—sarcoma	0.000228	0.000677	CcSEcCtD
Nefazodone—Cough—Doxorubicin—sarcoma	0.000227	0.000675	CcSEcCtD
Nefazodone—Shock—Epirubicin—sarcoma	0.000225	0.000671	CcSEcCtD
Nefazodone—Convulsion—Doxorubicin—sarcoma	0.000225	0.00067	CcSEcCtD
Nefazodone—Thrombocytopenia—Epirubicin—sarcoma	0.000224	0.000668	CcSEcCtD
Nefazodone—Hypertension—Doxorubicin—sarcoma	0.000224	0.000667	CcSEcCtD
Nefazodone—Tachycardia—Epirubicin—sarcoma	0.000224	0.000666	CcSEcCtD
Nefazodone—Hyperhidrosis—Epirubicin—sarcoma	0.000222	0.000659	CcSEcCtD
Nefazodone—Myalgia—Doxorubicin—sarcoma	0.000221	0.000658	CcSEcCtD
Nefazodone—Arthralgia—Doxorubicin—sarcoma	0.000221	0.000658	CcSEcCtD
Nefazodone—Chest pain—Doxorubicin—sarcoma	0.000221	0.000658	CcSEcCtD
Nefazodone—Anxiety—Doxorubicin—sarcoma	0.00022	0.000656	CcSEcCtD
Nefazodone—Discomfort—Doxorubicin—sarcoma	0.000219	0.00065	CcSEcCtD
Nefazodone—Anorexia—Epirubicin—sarcoma	0.000218	0.00065	CcSEcCtD
Nefazodone—Dry mouth—Doxorubicin—sarcoma	0.000216	0.000644	CcSEcCtD
Nefazodone—Hypotension—Epirubicin—sarcoma	0.000214	0.000637	CcSEcCtD
Nefazodone—Confusional state—Doxorubicin—sarcoma	0.000214	0.000636	CcSEcCtD
Nefazodone—Anaphylactic shock—Doxorubicin—sarcoma	0.000212	0.000631	CcSEcCtD
Nefazodone—Oedema—Doxorubicin—sarcoma	0.000212	0.000631	CcSEcCtD
Nefazodone—Infection—Doxorubicin—sarcoma	0.000211	0.000627	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000209	0.000621	CcSEcCtD
Nefazodone—Shock—Doxorubicin—sarcoma	0.000209	0.000621	CcSEcCtD
Nefazodone—Thrombocytopenia—Doxorubicin—sarcoma	0.000208	0.000618	CcSEcCtD
Nefazodone—Insomnia—Epirubicin—sarcoma	0.000207	0.000617	CcSEcCtD
Nefazodone—Tachycardia—Doxorubicin—sarcoma	0.000207	0.000616	CcSEcCtD
Nefazodone—Paraesthesia—Epirubicin—sarcoma	0.000206	0.000612	CcSEcCtD
Nefazodone—Hyperhidrosis—Doxorubicin—sarcoma	0.000205	0.00061	CcSEcCtD
Nefazodone—Dyspnoea—Epirubicin—sarcoma	0.000204	0.000608	CcSEcCtD
Nefazodone—Somnolence—Epirubicin—sarcoma	0.000204	0.000606	CcSEcCtD
Nefazodone—Anorexia—Doxorubicin—sarcoma	0.000202	0.000601	CcSEcCtD
Nefazodone—Dyspepsia—Epirubicin—sarcoma	0.000202	0.0006	CcSEcCtD
Nefazodone—Decreased appetite—Epirubicin—sarcoma	0.000199	0.000593	CcSEcCtD
Nefazodone—Hypotension—Doxorubicin—sarcoma	0.000198	0.00059	CcSEcCtD
Nefazodone—Pain—Epirubicin—sarcoma	0.000196	0.000583	CcSEcCtD
Nefazodone—Constipation—Epirubicin—sarcoma	0.000196	0.000583	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000193	0.000575	CcSEcCtD
Nefazodone—Insomnia—Doxorubicin—sarcoma	0.000192	0.000571	CcSEcCtD
Nefazodone—Paraesthesia—Doxorubicin—sarcoma	0.00019	0.000567	CcSEcCtD
Nefazodone—Dyspnoea—Doxorubicin—sarcoma	0.000189	0.000563	CcSEcCtD
Nefazodone—Feeling abnormal—Epirubicin—sarcoma	0.000189	0.000562	CcSEcCtD
Nefazodone—Somnolence—Doxorubicin—sarcoma	0.000189	0.000561	CcSEcCtD
Nefazodone—Gastrointestinal pain—Epirubicin—sarcoma	0.000187	0.000558	CcSEcCtD
Nefazodone—Dyspepsia—Doxorubicin—sarcoma	0.000187	0.000555	CcSEcCtD
Nefazodone—Decreased appetite—Doxorubicin—sarcoma	0.000184	0.000548	CcSEcCtD
Nefazodone—Urticaria—Epirubicin—sarcoma	0.000182	0.000542	CcSEcCtD
Nefazodone—Pain—Doxorubicin—sarcoma	0.000181	0.00054	CcSEcCtD
Nefazodone—Constipation—Doxorubicin—sarcoma	0.000181	0.00054	CcSEcCtD
Nefazodone—Abdominal pain—Epirubicin—sarcoma	0.000181	0.000539	CcSEcCtD
Nefazodone—Body temperature increased—Epirubicin—sarcoma	0.000181	0.000539	CcSEcCtD
Nefazodone—Feeling abnormal—Doxorubicin—sarcoma	0.000175	0.00052	CcSEcCtD
Nefazodone—Gastrointestinal pain—Doxorubicin—sarcoma	0.000173	0.000516	CcSEcCtD
Nefazodone—Hypersensitivity—Epirubicin—sarcoma	0.000169	0.000502	CcSEcCtD
Nefazodone—Urticaria—Doxorubicin—sarcoma	0.000168	0.000501	CcSEcCtD
Nefazodone—Body temperature increased—Doxorubicin—sarcoma	0.000168	0.000499	CcSEcCtD
Nefazodone—Abdominal pain—Doxorubicin—sarcoma	0.000168	0.000499	CcSEcCtD
Nefazodone—Asthenia—Epirubicin—sarcoma	0.000164	0.000489	CcSEcCtD
Nefazodone—Pruritus—Epirubicin—sarcoma	0.000162	0.000482	CcSEcCtD
Nefazodone—Diarrhoea—Epirubicin—sarcoma	0.000157	0.000467	CcSEcCtD
Nefazodone—Hypersensitivity—Doxorubicin—sarcoma	0.000156	0.000465	CcSEcCtD
Nefazodone—Asthenia—Doxorubicin—sarcoma	0.000152	0.000453	CcSEcCtD
Nefazodone—Dizziness—Epirubicin—sarcoma	0.000152	0.000451	CcSEcCtD
Nefazodone—Pruritus—Doxorubicin—sarcoma	0.00015	0.000446	CcSEcCtD
Nefazodone—Vomiting—Epirubicin—sarcoma	0.000146	0.000434	CcSEcCtD
Nefazodone—Diarrhoea—Doxorubicin—sarcoma	0.000145	0.000432	CcSEcCtD
Nefazodone—Rash—Epirubicin—sarcoma	0.000145	0.00043	CcSEcCtD
Nefazodone—Dermatitis—Epirubicin—sarcoma	0.000144	0.00043	CcSEcCtD
Nefazodone—Headache—Epirubicin—sarcoma	0.000144	0.000427	CcSEcCtD
Nefazodone—Dizziness—Doxorubicin—sarcoma	0.00014	0.000417	CcSEcCtD
Nefazodone—Nausea—Epirubicin—sarcoma	0.000136	0.000405	CcSEcCtD
Nefazodone—Vomiting—Doxorubicin—sarcoma	0.000135	0.000401	CcSEcCtD
Nefazodone—Rash—Doxorubicin—sarcoma	0.000134	0.000398	CcSEcCtD
Nefazodone—Dermatitis—Doxorubicin—sarcoma	0.000134	0.000397	CcSEcCtD
Nefazodone—Headache—Doxorubicin—sarcoma	0.000133	0.000395	CcSEcCtD
Nefazodone—Nausea—Doxorubicin—sarcoma	0.000126	0.000375	CcSEcCtD
